Showing results (131-140 of 137) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Cancer Science|June 13, 2020
Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesotheliomaDaisuke Horio, Toshiyuki Minami, Hidemi Kitai, et al.Anticancer Research|April 28, 2026
Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI ResistanceHaruka Nakatani, Hayato Kawachi, Tadaaki Yamada, et al.Lung Cancer (Amsterdam, Netherlands)|February 19, 2025
Exploration of clinical Biomarkers for guiding treatment selection between chemotherapy and combination therapy with Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Mutant NSCLC patients after EGFR-TKI Therapy: The SPIRAL-STEP studyKenji Morimoto, Tadaaki Yamada, Naoki Furuya, et al.International Journal of Clinical Oncology|July 21, 2025
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort studyKenji Morimoto, Tadaaki Yamada, Naoki Furuya, et al.Clinical Lung Cancer|August 15, 2025
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR MutationsTae Hata, Tadaaki Yamada, Naoki Furuya, et al.Targeted Oncology|April 24, 2025
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI FailureKenji Morimoto, Tadaaki Yamada, Naoki Furuya, et al.Science (New York, N.Y.)|May 10, 2011
The Selaginella genome identifies genetic changes associated with the evolution of vascular plantsJo Ann Banks, Tomoaki Nishiyama, Mitsuyasu Hasebe, et al.Pageof 14